Turner Investments’s Ligand Pharmaceuticals LGND Stock Holding History

Turner Investments’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-3,206	Closed	-$272K	–	52
2017 Q3	$272K	Buy	+3,206	New	+$254K	1.23%	34
2017 Q1	–	Sell	-16,030	Closed	-$1.02M	–	244
2016 Q4	$1.02M	Sell	16,030 -4,569	-22%	-$288K	0.41%	93
2016 Q3	$1.31M	Sell	20,599 -69,217	-77%	-$5.08M	0.43%	79
2016 Q2	$6.68M	Sell	89,816 -8,015	-8%	-$595K	2.09%	3
2016 Q1	$6.54M	Buy	97,831 +65,771	+205%	+$4M	1.77%	5
2015 Q4	$2.17M	Buy	32,060 +24,045	+300%	+$1.48M	0.45%	70
2015 Q3	$428K	Sell	8,015 -36,949	-82%	-$2.24M	0.09%	199
2015 Q2	$2.83M	Buy	+44,964	New	+$2.45M	0.52%	66

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

DMK

David M. Knott $275M AUM 59.23% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Turner Investments's LGND Position: Q4 2017 in Review

Turner Investments sold out of Ligand Pharmaceuticals (LGND) in Q4 2017, closing a stake of 3,206 shares — an estimated $272K sold.

Turner Investments first reported a position in LGND in Q2 2015 and held it in 8 quarters. The position peaked at $6.68M in Q2 2016. 298 funds tracked by Wall St. Rank hold LGND as of Q4 2017.

Turner Investments reported no remaining Ligand Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
Turner Investments sold 3,206 Ligand Pharmaceuticals shares in Q4 2017, an estimated $272K.
Turner Investments first reported a position in Ligand Pharmaceuticals in Q2 2015 and held it in 8 quarters.
Turner Investments's Ligand Pharmaceuticals position peaked at $6.68M in Q2 2016.
298 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2017.

Based on Turner Investments's 13F filing for Q4 2017, filed 2 Feb 2018.